Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network.

× No keyword cloud information.

14 in total

1. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.

Authors: G Dietrich; M D Kazatchkine
Journal: J Clin Invest Date: 1990-03 Impact factor: 14.808

2. Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin.

Authors: P Berchtold; G L Dale; P Tani; R McMillan
Journal: Blood Date: 1989-11-15 Impact factor: 22.113

3. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.

Authors: Y Sultan; M D Kazatchkine; P Maisonneuve; U E Nydegger
Journal: Lancet Date: 1984-10-06 Impact factor: 79.321

4. IgG autoantibody activity in normal mouse serum is controlled by IgM.

Authors: M Adib; J Ragimbeau; S Avrameas; T Ternynck
Journal: J Immunol Date: 1990-12-01 Impact factor: 5.422

5. A V region-connected autoreactive subfraction of normal human serum immunoglobulin G.

Authors: G Dietrich; S V Kaveri; M D Kazatchkine
Journal: Eur J Immunol Date: 1992-07 Impact factor: 5.532

6. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.

Authors: Y Sultan; F Rossi; M D Kazatchkine
Journal: Proc Natl Acad Sci U S A Date: 1987-02 Impact factor: 11.205

Review 7. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.

Authors: N Ronda; V Hurez; M D Kazatchkine
Journal: Vox Sang Date: 1993 Impact factor: 2.144

8. Expression and control of the natural autoreactive IgG repertoire in normal human serum.

Authors: V Hurez; S V Kaveri; M D Kazatchkine
Journal: Eur J Immunol Date: 1993-04 Impact factor: 5.532

9. Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura.

Authors: J B Bussel; R P Kimberly; R D Inman; I Schulman; C Cunningham-Rundles; N Cheung; E M Smithwick; J O'Malley; S Barandun; M W Hilgartner
Journal: Blood Date: 1983-08 Impact factor: 22.113

10. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.

Authors: F Rossi; Y Sultan; M D Kazatchkine
Journal: Clin Exp Immunol Date: 1988-11 Impact factor: 4.330

4 in total

Review 1. Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin.

Authors: S C Jordan; M Toyoda
Journal: Clin Exp Immunol Date: 1994-07 Impact factor: 4.330

2. Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates.

Authors: K S Sivasai; T Mohanakumar; D Phelan; S Martin; M E Anstey; D C Brennan
Journal: Clin Exp Immunol Date: 2000-03 Impact factor: 4.330

3. Pulmonary infections associated with systemic capillary leak syndrome attacks in a patient with hypogammaglobulinemia.

Authors: K Lassoued; J P Clauvel; T Similowski; B Autran; D Bengoufa; E Oksenhendler
Journal: Intensive Care Med Date: 1998-09 Impact factor: 17.440

Review 4. Current Desensitization Strategies in Heart Transplantation.

Authors: Marlena V Habal
Journal: Front Immunol Date: 2021-08-24 Impact factor: 8.786

4 in total